It is essential to ensure the safety of vaccines. In vitro safety assessment is a prerequisite for transferring candidate vaccines from laboratory to clinical practice, including product characterization, toxicology, adjuvant toxicity and stability, immunogenicity studies, and all aspects of microbial contamination testing. Creative Biolabs offers a range of pre-clinical in vitro tests to ensure these key attributes.
Creative Biolabs' safety assessments are conducted in the following categories:
In vitro safety studies conducted prior to the start of clinical trials (pre-clinical) identified potential safety issues and helped prevent possible harm to humans. Potential problems include toxicity caused by active ingredients or excipients, reactions to trace impurities (e.g., production substrates), and interactions between other vaccine components administered simultaneously.
In vitro safety assessment that Creative Biolabs includes:
With our professional team of experts, Creative Biolabs is dedicated to helping you identify the most promising candidate vaccines to help you enter the post-development phase.
For more details, please feel free to contact us for project quotations and more detailed information.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy with the complete TCR without HLA dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE